Back to Peptides
Peptides

IGF-1 LR3Evidence & Dosage

Modified IGF-1 with a long half-life — hypertrophy, the cancer-risk debate.

Evidence at a glance

Total studies
9
With abstract
9
Meta / Systematic / RCT
0
Highly cited
3
Publication years
2003–2026

IGF-1 LR3 in the context of Peptides

This topic is part of our "Peptides" world. There you'll find methodology, evidence and the highest-impact levers — plus the order in which they sensibly build on each other.

Go to Peptides

Top studies on IGF-1 LR3

Ranked by influential-citation count and publication year.

  1. Potential roles of insulin and IGF-1 in Alzheimer's disease.

    Trends in neurosciences200348 influential citations

    Aging is characterized by a significant decline of metabolic and hormonal functions, which often facilitates the onset of severe age-associated pathologies. One outstanding example of this is the reported association of deranged signaling…

  2. Function of matrix IGF-1 in coupling bone resorption and formation.

    Journal of molecular medicine (Berlin, Germany)201436 influential citations

    Balancing bone resorption and formation is the quintessential component for the prevention of osteoporosis. Signals that determine the recruitment, replication, differentiation, function, and apoptosis of osteoblasts and osteoclasts direct…

  3. Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice.

    Journal of Alzheimer's disease : JAD2025n=19E21 influential citations

    Insulin-like growth factor-1 (IGF-1) promotes neurogenesis, cell survival, and glial function, making it a promising candidate therapy in Alzheimer's disease (AD). Long arginine 3-IGF-1 (LR3-IGF-1) is a potent IGF-1 analogue. We sought to…

  4. L-Citrulline Improves IGF-1 Signaling Pathway in Preeclampsia via Polyamines.

    Hypertension (Dallas, Tex. : 1979)2025E3 influential citations

    Preeclampsia is a severe pregnancy complication with no effective pharmacological therapy available. We previously demonstrated that L-citrulline supplementation improves preeclampsia phenotypes in Dahl salt-sensitive rats, an animal model…

  5. The IGF signaling axis in thyroid cancer: biological complexity and therapeutic challenges.

    Endocr Connect2026Review

    Dysregulation of the insulin-like growth factor (IGF) axis plays an important role in thyroid cancer progression, dedifferentiation, and therapeutic resistance. While most differentiated thyroid cancers have favorable outcomes, a…

  6. Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration.

    International journal of biological macromolecules2025n=5

    Peripheral nerve injuries lead to significant functional deficits, with no treatment achieving complete recovery. Autologous nerve grafting remains the gold standard, but it is limited by donor site morbidity. Artificial nerve conduits…

  7. Signaling Pathways of the Insulin-like Growth Factor Binding Proteins.

    Endocrine reviews2023

    The 6 high-affinity insulin-like growth factor binding proteins (IGFBPs) are multifunctional proteins that modulate cell signaling through multiple pathways. Their canonical function at the cellular level is to impede access of…

  8. The interrelationship between prostate cancer and osteoporosis: new perspectives on shared molecular pathways and treatment strategies.

    International journal of surgery (London, England)2026E

    Osteoporosis is frequently regarded as a complication associated with androgen deprivation therapy (ADT) in patients with prostate cancer. Nevertheless, a notably higher incidence of osteoporosis has been observed in prostate cancer…

  9. Assessing the Role of Lifestyle in Modulating Serum IGF-1 and Association with Breast Cancer Risk among Palestinian Women in the Gaza Strip: A Case-Control Study.

    Asian Pacific journal of cancer prevention : APJCP2026E

    Breast cancer (BC) continues to be one of the most commonly diagnosed cancers worldwide, predominantly affecting women. Insulin-like growth factor-1 (IGF-1) is vital for cellular growth and metabolism. Dysregulation of IGF-1 has been…

More topics in Peptides

Peptides Overview

Peptides, BPC-157, TB-500, safety and the state of the evidence.

Administration Routes

Subcutaneous, intramuscular, nasal, oral, topical — bioavailability and safety.

Autoimmunity Risk

Immune modulation can both promote tolerance and tip into dysregulation.

BPC-157

Peptide for tissue regeneration, healing, and athletic recovery.

Cerebrolysin

A pig-brain peptide mix, stroke studies, not approved in Germany.

CJC-1295

GHRH analog, half‑life variants and pulse patterns.

Dihexa

Angiotensin derivative, cognitive/neuroplasticity signals in animal models.

GHK-Cu

Copper peptide for skin health, anti-aging, and wound healing.

GHRP-2

GH releaser, older generation, appetite stimulation as a side effect.

GHRP-6

GH releaser with a strong appetite component.

GLP-1 Rebound

Weight regain after stopping without lifestyle anchors.

GLP-1 Side Effects

Nausea, gastric emptying, muscle loss, pancreatitis risk.

Hexarelin

GH releaser, fast tolerance build-up, cardiac signals.

Immune Modulation

Automatisch via Trend Scout entdeckt. Supplements targeting inflammation and immune resilience remain a central research area.. PubMed: 11956 Ergebnisse.

Injection Safety

Sterile technique, bacteriostatic water, skin disinfection — a medical topic.

Ipamorelin

Selective GH releaser, cortisol‑sparing, and stack combinations.

KPV

An alpha-MSH fragment — anti-inflammatory, gut, skin, early research.

Liraglutide

First-generation GLP-1 for diabetes/obesity — daily, smaller effect size.

LL-37

Antimicrobial peptide, wound healing, immune modulation, early research.

MK-677

Ghrelin mimetic, not strictly a peptide — sleep, appetite, glucose risk.

Related topics from other worlds